Catalyst Pharmaceuticals Inc (CPRX)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	196,937	187,587	166,038	139,449	121,047	104,467	89,546	77,282	69,321	64,380	61,342	55,686	57,801	75,131	78,120	79,077	74,891	45,268	23,182	4,962
Revenue (ttm)	US$ in thousands	398,204	348,393	302,949	256,480	214,203	191,755	170,465	153,717	140,833	133,539	126,902	120,142	119,073	118,181	119,761	118,994	102,306	72,683	41,786	12,948
Gross profit margin		49.46%	53.84%	54.81%	54.37%	56.51%	54.48%	52.53%	50.28%	49.22%	48.21%	48.34%	46.35%	48.54%	63.57%	65.23%	66.45%	73.20%	62.28%	55.48%	38.32%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $196,937K ÷ $398,204K
= 49.46%

Catalyst Pharmaceuticals Inc's gross profit margin has shown fluctuating trends over the past five years. The margin has ranged from as low as 38.32% in March 2019 to as high as 73.20% in March 2020.

In recent quarters, the gross profit margin has shown some volatility, with a decrease from 56.51% in December 2022 to 49.46% in December 2023. Despite this decline, the current margin remains relatively healthy compared to historical figures.

Overall, Catalyst Pharmaceuticals Inc's gross profit margin has demonstrated variability over time, potentially influenced by factors such as changes in revenue, cost of goods sold, and pricing strategies. This metric serves as a key indicator of the company's profitability before accounting for operating expenses. Further analysis of the company's cost structure and sales performance may provide insights into the drivers behind these fluctuations.